Search results
ASCO24: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Pharmaceutical Technology via Yahoo Finance· 2 days agoUS-based Rakuten Medical has announced positive interim data from the Phase Ib/II trial of its...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 7 days agoBut in newborns and older adults it can be serious or even deadly. Moderna will rival Pfizer and...
Pharma M&A: The top high value deals in 2023
Pharmaceutical Technology via Yahoo Finance· 1 day agoFrom Pfizer’s Seagen acquisition to Sanofi’s deal with Provention Bio, Pharmaceutical Technology lists the highest value pharma mergers and acquisitions...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 6 days agoFor Immediate Release Chicago, IL – June 21, 2024 – Zacks.com announces the list of stocks featured...
George W. Bush among 2024 Bill Foege Global Health Awards recipients - Atlanta Business Chronicle
The Business Journals· 16 hours agoThe 8th annual awards will recognize former President George W. Bush and former first lady Laura...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoShares are up 0.3% at GBP125.18. (christian.moess@wsj.com) 0337 ET – Merck KGaA’s discontinued phase 3 trial for its xevinapant drug to treat...
Spirit Aero downgraded, Skyworks upgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 7 days agoThe firm cites limited visibility after the company announced the FDA placed a partial clinical hold...
Norton Rose Adds Former NY Prosecutor to Investigations Team
Bloomberg Law· 2 days agoSpektor, former assistant United States attorney in the Eastern District of New York, is joining the firm as a partner in its regulatory, investigations, securities and compliance practice, ...
Successful heart drug trial prompts Alnylam stock to jump 35 percent
Quartz· 3 days agoThe pharma company plans to seek regulator approval to treat a serious heart condition
Decades of gene therapy research pay off big for Madison company
Wisconsin State Journal· 7 days agoThirty years ago, when the idea that would give rise to Mirus Bio took shape in a UW-Madison...
